Diabetes and depression care among Medicaid beneficiaries

Journal of Health Care for the Poor and Underserved

Volumn 17, Issue 1, 2006, Pages 141-161

  Sambamoorthi, Usha ^a,b   Olfson, Mark ^c   Wei, Wenhui ^a   Crystal, Stephen ^a  

^a RUTGERS UNIVERSITY   (United States)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Adult; Antidepressants; Depression; Diabetes mellitus; Medicaid

Indexed keywords

ANTIDEPRESSANT AGENT;

ADOLESCENT; ADULT; ARTICLE; COMORBIDITY; COMPARATIVE STUDY; DEPRESSION; DIABETES MELLITUS; DRUG UTILIZATION; FEMALE; HEALTH CARE QUALITY; HUMAN; MALE; MEDICAID; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; STATISTICAL MODEL; UNITED STATES; UTILIZATION REVIEW;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS; COMORBIDITY; DEPRESSIVE DISORDER; DIABETES MELLITUS; DRUG UTILIZATION; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MEDICAID; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; QUALITY OF HEALTH CARE; UNITED STATES;

EID: 33644780818     PISSN: 10492089     EISSN: None     Source Type: Journal    
DOI: 10.1353/hpu.2006.0034     Document Type: Article

References (87)

1. Evans DL, Charney DS, Lewis L, et al. Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry. 2005 Aug 1;58(3):175-89.
2. Goldman LS, Nielsen NH, Champion HC. Awareness, diagnosis, and treatment of depression. J Gen Intern Med. 1999 Sep;14(9):569-80.
3. Preboth M. Clinical review of recent findings on the awareness, diagnosis and treatment of depression. Am Fam Physician. 2000 May 15;61(10):3158, 3160, 3167-8.
4. de Groot M, Jacobson AM, Samson JA, et al. Glycemic control and major depression in patients with type 1 and type 2 diabetes mellitus. J Psychosom Res. 1999 May;46(5):425-35.
5. Gavard JA, Lustman PJ, Clouse RE. Prevalence of depression in adults with diabetes. An epidemiological evaluation. Diabetes Care. 1993 Aug;16(8):1167-78.
6. Anderson RJ, Freedland KE, Clouse RE, et al. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. 2001 Jun;24(6):1069-78.
7. Tellez-Zenteno JF, Cardiel MH. Risk factors associated with depression in patients with type 2 diabetes mellitus. Arch Med Res. 2002 Jan-Feb;33(1):53-60.
8. Lustman PJ, Griffith LS, Clouse RE, et al. Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial. Psychosom Med. 1997 May-Jun;59(3):241-50.
9. Peyrot M, Rubin RR. Persistence of depressive symptoms in diabetic adults. Diabetes Care. 1999 Mar;22(3):448-52.
10. Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med. 2000 Nov 27;160(21):3278-85.
11. Egede LE, Zheng D, Simpson K. Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diabetes Care. 2002 Mar;25(3):464-70.
12. Simon GE, Katon WJ, Lin EH, et al. Diabetes complications and depression as predictors of health service costs. Gen Hosp Psychiatry. 2005 Sep-Oct;27(5):344-51.
13. Gross R, Olfson M, Gameroff MJ, et al. Depression and glycemic control in Hispanic primary care patients with diabetes. J Gen Intern Med. 2005 May;20(5):460-6.
14. Clouse RE, Lustman PJ, Freedland KE, et al. Depression and coronary heart disease in women with diabetes. Psychosom Med. 2003 May-Jun;65(3):376-83.
15. Zhang X, Norris SL, Gregg EW, et al. Depressive symptoms and mortality among persons with and without diabetes. Am J Epidemiol. 2005 Apr 1;161(7):652-60.
16. Egede LE, Nietert PJ, Zheng D. Depression and all-cause and coronary heart disease mortality among adults with and without diabetes. Diabetes Care. 2005 Jun;28(6):1339-45.
17. Chapman DP, Perry GS, Strine TW. The vital link between chronic disease and depressive disorders. Prev Chronic Dis. 2005 Jan;2(1):A14.
18. Simon GE, Von Korff M, Lin E. Clinical and functional outcomes of depression treatment in patients with and without chronic medical illness. Psychol Med. 2005 Feb;35(2):271-9.
19. Lustman PJ, Clouse RE. Treatment of depression in diabetes: impact on mood and medical outcome. J Psychosom Res. 2002 Oct;53(4):917-24.
20. Goodnick PJ. Use of antidepressants in treatment of comorbid diabetes mellitus and depression as well as in diabetic neuropathy. Ann Clin Psychiatry. 2001 Mar;13(1):31-41.
21. Goodnick PJ, Henry JH, Buki VM. Treatment of depression in patients with diabetes mellitus. J Clin Psychiatry. 1995 Apr;56(4):128-36.
22. Goodnick PJ, Kumar A, Henry JH, et al. Sertraline in coexisting major depression and diabetes mellitus. Psychopharmacol Bull. 1997;33(2):261-4.
23. Lustman PJ, Freedland KE, Griffith LS, et al. Predicting response to cognitive behavior therapy of depression in type 2 diabetes. Gen Hosp Psychiatry. 1998 Sep;20(5):302-6.
24. Lustman PJ, Freedland KE, Griffith LS, et al. Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial. Diabetes Care. 2000 May;23(5):618-23.
25. Rubin RR, Ciechanowski P, Egede LE, et al. Recognizing and treating depression in patients with diabetes. Curr Diab Rep. 2004 Apr;4(2):119-25.
26. Williams JW Jr, Katon W, Lin EH, et al. The effectiveness of depression care management on diabetes-related outcomes in older patients. Ann Intern Med. 2004 Jun 15;140(12):1015-24.
27. Katon WJ, Von Korff M, Lin EH, et al. The Pathways Study: a randomized trial of collaborative care in patients with diabetes and depression. Arch Gen Psychiatry. 2004 Oct;61(10):1042-9.
28. Skaer TL, Robison LM, Sclar DA, et al. Use of antidepressant pharmacotherapy within the first year after diagnosis of diabetes mellitus: a study of a medicaid population. Current Ther Res. 1999;60(8):415-22.
29. Zuckerman S, Cuellar AE, Holahan J. Questions for states as they turn to medicaid managed Care. (New Federalism: Issues and Options for States, No. A-11). Washington, D.C.: Urban Institute, 1997 Aug 1. Available at http://www.urban.org/UploadedPDF/anf_a11.pdf.
30. Gist YJ, Hetzel LI. We the people: aging in the United States. (Pub. No. CENSR-19.) Washington, D.C.: U.S. Census Bureau, 2004 Dec. Available at http://www.census. gov/prod/2004pubs/censr-19.pdf.
31. Frank RG, Busch SH, Berndt ER. Measuring prices and quantities of treatment for depression. Am Econ Rev. 1998 May;88(2):106-11.
32. Sambamoorthi U, Walkup J, Olfson M, et al. Antidepressant treatment and health services utilization among HIV-infected medicaid patients diagnosed with depression. J Gen Intern Med, 2000 May;15(5):311-20.
33. Thompson D, Buesching D, Gregor KJ, et al. Patterns of antidepressant use and their relation to costs of care. Am J Managed Care. 1996 Oct;2:1239-46.
34. Wingert TD, Kralewski JE, Lindquist TJ, et al. Constructing episodes of care from encounter and claims data: some methodological issues. Inquiry. 1995-96 Winter;32(4):430-43.
35. Lamberts H, Hofmans-Okkes I. Episode of care: a core concept in family practice. J Fam Pract. 1996 Feb;42(2):161-9.
36. U.S. Department of Health and Human Services. International Classification of Diseases, 9th Revision, Clinical Modification: ICD-9-CM, 3rd ed, Vol 1. (DHHS Pub. No. PHS 89-1260.) Washington, DC: US Government Printing Office, 1989.
37. Hebert PL, Geiss LS, Tierney EF, et al. Identifying persons with diabetes using Medicare claims data. Am J Med Qual. 1999 Nov-Dec;14(6):270-7.
38. Medical Economics. Physician's Desk Reference, 51st ed. Montvale, NJ: Thomson Healthcare, 1997.
39. Perry PJ, Alexander B and Liskow BI. Psychotropic Drug Handbook, 7th ed. Washington, D.C.: American Psychiatric Press, 1997.
40. Holmboe ES. Oral antihyperglycemic therapy for type 2 diabetes: clinical applications. JAMA. 2002 Jan 16;287(3):373-6.
41. Inzucchi SE. Oral antihyperglycemic therapy for type 2 diabetes: scientific review. JAMA. 2002 Jan 16;287(3):360-72.
42. Watkins LL, Schneiderman N, Blumenthal JA, et al. Cognitive and somatic symptoms of depression are associated with medical comorbidity in patients after acute myocardial infarction. Am Heart J. 2003 Jul;146(1):48-54.
43. Fischer LR, Wei F, Rolnick SJ, et al. Geriatric depression, antidepressant treatment, and healthcare utilization in a health maintenance organization. J Am Geriatr Soc. 2002 Feb;50(2):307-12.
44. Balkrishnan R, Christensen DB, Bowton DL. Self-reported health status, prophylactic medication use, and healthcare costs in older adults with asthma. J Am Geriatr Soc. 2002 May;50(5):924-9.
45. Beddhu S, Bruns FJ, Saul M, et al. A simple comorbidity scale predicts clinical outcomes and costs in dialysis patients. Am J Med. 2000 Jun 1;108(8):609-13.
46. Matsui K, Goldman L, Johnson PA, et al. Comorbidity as a correlate of length of stay for hospitalized patients with acute chest pain. J Gen Intern Med. 1996 May;11(5):262-8.
47. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992 Jun;45(6):613-9.
48. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-83.
49. Kashner TM. Agreement between administrative files and written medical records: a case of the Department of Veterans Affairs. Med Care. 1998 Sep;36(9):1324-36.
50. Rawson NS, Malcolm E, D'Arcy C. Reliability of the recording of schizophrenia and depressive disorder in the Saskatchewan health care datafiles. Soc Psychiatry Psychiatr Epidemiol. 1997 May;32(4):191-9.
51. Walkup JT, Boyer CA, Kellermann SL. Reliability of Medicaid claims files for use in psychiatric diagnoses and service delivery. Adm Policy Ment Health. 2000 Jan;27(3):129-39.
52. Heckman J. The common structure of statistical models of truncation, sample selection, and limited dependent variables and a simple estimator of such models. Annals of Economic and Social Measurement. 1976;5:475-92.
53. StataCorp. Stata Statistical Software. College Station: Stata Corporation, 2001.
54. Centers for Disease Control and Prevention. Trends in the prevalence and incidence of self-reported diabetes mellitus - United States, 1980-1994. MMWR Morb Mortal Wkly Rep. 1997 Oct 31;46(43):1014-18.
55. Pignone MP, Gaynes BN, Rushton JL, et al. Screening for depression in adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002 May 21;136(10):765-76.
56. Sharp LK, Lipsky MS. Screening for depression across the lifespan: a review of measures for use in primary care settings. Am Fam Physician. 2002 Sep 15;66(6):1001-8.
57. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2005 Jan;28 Suppl 1:S4-S36.
58. Sclar DA, Robison LM, Skaer TL, et al. What factors influence the prescribing of antidepressant pharmacotherapy? An assessment of national office-based encounters. Int J Psychiatry Med. 1998;28(4):407-19.
59. Rubin RR, Knowler WC, Ma Y, et al. Depression symptoms and antidepressant medicine use in Diabetes Prevention Program participants. Diabetes Care. 2005 Apr;28(4):830-7.
60. Sirey JA, Meyers BS, Bruce ML, et al. Predictors of antidepressant prescription and early use among depressed outpatients. Am J Psychiatry, 1999 May;156(5):690-6.
61. Alvidrez J, Havassy BE. Racial distribution of dual-diagnosis clients in public sector mental health and drug treatment settings. J Health Care Poor Underserved. 2005 Feb;16(1):53-62.
62. Green-Hennessy S, Hennessy KD. Demographic differences in medication use among individuals with self-reported major depression. Psychiatr Serv. 1999 Feb;50(2):257-9.
63. Melfi CA, Croghan TW, Hanna MP, et al. Racial variation in antidepressant treatment in a Medicaid population. J Clin Psychiatry. 2000 Jan;61(1):16-21.
64. Harman JS, Edlund MJ, Fortney JC. Disparities in the adequacy of depression treatment in the United States. Psychiatr Serv. 2004 Dec;55(12):1379-85.
65. Sclar DA, Robinson LM, Skaer TL, et al. Antidepressant prescribing patterns: a comparison of blacks and whites in a medicaid population. Clin Drug Invest. 1998;16(2):135-140.
66. Sclar DA, Robison LM, Skaer TL, et al. Ethnicity and the prescribing of antidepressant pharmacotherapy: 1992-1995. Harv Rev Psychiatry. 1999 May-Jun;7(1):29-36.
67. Melfi CA, Croghan TW, Hanna MP. Access to treatment for depression in a Medicaid population. J Health Care Poor Underserved. 1999 May;10(2):201-15.
68. Harris MI. Diabetes in America: epidemiology and scope of the problem. Diabetes Care. 1998 Dec;21 Suppl 3:C11-4.
69. Gu K, Cowie CC, Harris MI. Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-1993. Diabetes Care. 1998 Jul;21(7):1138-45.
70. Nutting PA, Rost K, Smith J, et al. Competing demands from physical problems: effect on initiating and completing depression care over 6 months. Arch Fam Med. 2000 Nov-Dec;9(10):1059-64.
71. Bartels SJ, Horn S, Sharkey P, et al. Treatment of depression in older primary care patients in health maintenance organizations. Int J Psychiatry Med. 1997;27(3):215-31.
72. Olfson M, Marcus SC, Druss B, et al. National trends in the use of outpatient psychotherapy. Am J Psychiatry. 2002 Nov;159(11):1914-20.
73. Boyce P, Judd F. The place for the tricyclic antidepressants in the treatment of depression. Aust N Z J Psychiatry. 1999 Jun;33(3):323-7.
74. Dunner DL. Therapeutic considerations in treating depression in the elderly. J Clin Psychiatry. 1994 Dec;55 Suppl:48-58; discussion 59-60.
75. Koenig HG. Late-life depression: how to treat patients with comorbid chronic illness. Interview by Alice V. Luddington. Geriatrics. 1999 May;54(5):56-61; quiz 62.
76. Lebowitz BD, Pearson JL, Schneider LS, et al. Diagnosis and treatment of depression in late life. Consensus statement update. JAMA. 1997 Oct 8;278(14):1186-90.
77. Newhouse PA. Use of serotonin selective reuptake inhibitors in geriatric depression. J Clin Psychiatry. 1996;57 Suppl 5:12-22.
78. Porter RJ, O'Brien JT. SSRIs may well be best treatment for elderly depressed subjects. BMJ. 1998 Feb 21;316(7131):631.
79. Roose SP, Suthers KM. Antidepressant response in late-life depression. J Clin Psychiatry. 1998;59 Suppl 10:4-8.
80. Varner RV, Ruiz P, Small DR. Black and white patients response to antidepressant treatment for major depression. Psychiatr Q. 1998 Summer;69(2):117-25.
81. Sclar DA, Robinson LM, Skaer TL, et al. Trends in the prescribing of antidepressant pharmacotherapy: office-based visits, 1990-1995. Clin Ther. 1998 Jul-Aug;20(4):871-84; 870.
82. Mulrow CD, Cornell JA, Herrera CR, et al. Hypertension in the elderly. Implications and generalizability of randomized trials. JAMA. 1994 Dec 28;272(24):1932-8.
83. Wallihan DB, Stump TE, Callahan CM. Accuracy of self-reported health services use and patterns of care among urban older adults. Med Care. 1999 Jul;37(7):662-70.
84. Kessler RC, Wittchen HU, Abelson J, et al. Methodological Issues in Assessing Psychiatric Disorders With Self-Reports In: Stone AA, Turrkan JS, Bachrach CA, et al., eds. The science of self-report: implications for research and practice. Mahwah, NJ: Lawrence Erlbaum Associates; 229-55.
85. Bazargan M, Bazargan-Hejazi S, Baker RS. Treatment of self-reported depression among Hispanics and African Americans. J Health Care Poor Underserved. 2005 May;16(2):328-44.
86. Harman JS, Mulsant BH, Kelleher KJ, et al. Narrowing the gap in treatment of depression. Int J Psychiatry Med. 2001;31(3):239-53.
87. de Groot M, Lustman PJ. Depression among African-Americans with diabetes: a dearth of studies. Diabetes Care. 2001 Feb;24(2):407-8.